NZ Herald
A popular weight-loss drug used by celebrities overseas has been approved by New Zealand’s medicine regulatory body, with its producer hoping to make it accessible “as soon as possible”.
Associate Health Minister David Seymour is welcoming the move, but said the process of approving medicines in New Zealand remains too slow. The Herald understands the minister will be announcing changes to the pathway for approving new medicines later this week.
Wegovy is a semaglutide prescription injection developed by Danish healthcare company Novo Nordisk Pharmaceuticals. Semaglutide acts to regulate someone’s appetite to increase their feeling of fullness and reduce craving for food.
